Effect of acupuncture on patients with chronic obstructive pulmonary disease: A multicenter randomized controlled trial

被引:1
作者
Li, Jiansheng [1 ,4 ]
Xie, Yang [3 ,4 ]
Wang, Yanjun [5 ]
Wu, Lei [6 ]
Yu, Xuefeng [7 ]
Bai, Li [8 ]
Shao, Suju [9 ]
Zhou, Miao [10 ]
Zhang, Mingli [11 ]
Yu, Xueqing [1 ,2 ,3 ]
Han, Weihong [1 ,2 ]
Li, Xuanlin [1 ,2 ]
Chen, Tao [4 ,12 ]
机构
[1] Henan Univ Chinese Med, Coconstruct Collaborat Innovat Ctr Chinese Med & R, 156 Jin Sshui East Rd, Zhengzhou 450046, Henan, Peoples R China
[2] Henan Univ Chinese Med, Henan Key Lab Chinese Med Resp Dis, 156 Jin Shui East Rd, Zhengzhou 450046, Henan, Peoples R China
[3] First Affiliated Hosp Henan Univ Chinese Med, Dept Resp Dis, 19 Ren Min Rd, Zhengzhou 450046, Henan, Peoples R China
[4] Henan Univ Chinese Med, Affiliated Hosp 1, Henan Prov Clin Res Ctr Resp Dis, Henan Int Joint Lab Evidence Based Evaluat Resp Di, Zhengzhou, Henan, Peoples R China
[5] Hebei Prov Hosp Tradit Chinese Med, Dept Acupuncture & Moxibust Rehabil, 389 Zhong Shan East Rd, Shijiazhuang 050011, Hebei, Peoples R China
[6] Hebei Prov Hosp Tradit Chinese Med, Dept Urol, 389 Zhong Shan East Rd, Shijiazhuang 050011, Hebei, Peoples R China
[7] Liaoning Tradit Chinese Med Univ, Affiliated Hosp 2, Dept Oncol, 60 Huang He North Rd, Shenyang, Peoples R China
[8] Shanxi Hosp Integrated Tradit & Western Med, 13 Fu Dong Rd 63, Taiyuan 030013, Shanxi, Peoples R China
[9] Henan Univ Chinese Med, Affiliated Hosp 1, Dept Neurol, 63 Dong Ming Rd, Zhengzhou 450000, Henan, Peoples R China
[10] Henan Univ Chinese Med, Dept Resp Dis, Affiliated Hosp 1, 63 Dong Ming Rd, Zhengzhou 450000, Peoples R China
[11] Henan Integrat Med Hosp, Dept Resp Dis, 7 Cheng Bei Rd, Zhengzhou 450003, Henan, Peoples R China
[12] Univ Liverpool Liverpool Sch Trop Med, Global Hlth Trials Unit, Liverpool, England
基金
中国国家自然科学基金;
关键词
Chronic obstructive pulmonary disease; Acupuncture; Randomized controlled trial; Cost-effectiveness analysis; COPD; STIMULATION; DYSPNEA;
D O I
10.1016/j.ctim.2025.103146
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Background: Chronic obstructive pulmonary disease (COPD) is a common and frequently occurring disease that seriously endangers health, causing a heavy economic burden on patients and society. Acupuncture has been reported to have a therapeutic effect on patients with chronic obstructive pulmonary disease (COPD). However, compared with medications, it is difficult to identify a superior therapy. Therefore, the aim of this study was to evaluate the efficacy and safety of acupuncture, conventional drug and acupuncture plus conventional drug in the treatment of COPD. Methods: This was a multicenter, open-label randomized controlled trial (RCT) through a central randomization system. A total of 150 COPD patients were randomly assigned at a 1:1:1 ratio to the acupuncture group, conventional drug group or acupuncture plus conventional drug group for 12 weeks of treatment, followed by 12 weeks of untreated follow-up. The primary outcomes included the six-minute walk distance (6MWD) and St. George's Respiratory Questionnaire (SGRQ), and the secondary outcomes included the modified Medical Research Council dyspnea scale (mMRC), acute exacerbation, lung function, and quality of life (COPD assessment test). Statistical analysis was conducted via SPSS software (version 26.0). Results: A total of 150 patients were included in the study, and 143 patients completed the trial. There were time effects, group effects and interaction effects in the three groups (P < 0.05). Compared with that in the conventional drug group, the 6MWD in the acupuncture plus conventional drug group increased significantly at 4, 8, and 12 weeks of treatment and at 12 weeks of follow-up. The difference was statistically significant (P < 0.05). The symptom scores, motor scores, impact scores and total SGRQ scores at different time points in the three groups tended to change with time, with a time effect (P < 0.05), and there was no group or interaction effect (P > 0.05). Among the secondary outcomes, there were time effects on the number of acute exacerbations, forced expiratory volume in one second (FEV1) and forced expiratory volume in one second/forced vital capacity (FEV1/FVC) at different time points in the three groups (P < 0.05). mMRC had time and group effects (P < 0.05). CAT had time effects, group effects and interaction effects (P < 0.05). Conclusions: Compared with the acupuncture group and the conventional drug group, the acupuncture plus conventional drug group was better at improving exercise ability, improving quality of life, and reducing dyspnea. It is safe and effective for the treatment of chronic obstructive pulmonary disease in the stable period, which can provide a reference for further related research.
引用
收藏
页数:16
相关论文
共 41 条
[1]   Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary [J].
Agusti, Alvar ;
Celli, Bartolome R. ;
Criner, Gerard J. ;
Halpin, David ;
Anzueto, Antonio ;
Barnes, Peter ;
Bourbeau, Jean ;
Han, MeiLan K. ;
Martinez, Fernando J. ;
de Oca, Maria Montes ;
Mortimer, Kevin ;
Papi, Alberto ;
Pavord, Ian ;
Roche, Nicolas ;
Salvi, Sundeep ;
Sin, Don D. ;
Singh, Dave ;
Stockley, Robert ;
Varela, M. Victorina Lopez ;
Wedzicha, Jadwiga A. ;
Vogelmeier, Claus F. .
EUROPEAN RESPIRATORY JOURNAL, 2023, 61 (04)
[2]  
[Anonymous], 2017, PNEUMOLOGIE, V71, P9
[3]  
[Anonymous], 2017, Chronic obstructive pulmonary disease
[4]   Inhalation therapies in COPD - adverse drug reactions impact on emergency department presentations [J].
Bergs, Ingmar ;
Just, Katja S. ;
Scholl, Catharina ;
Dreher, Michael ;
Stingl, Julia C. .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 79 (02) :219-227
[5]   Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease [J].
Bestall, JC ;
Paul, EA ;
Garrod, R ;
Garnham, R ;
Jones, PW ;
Wedzicha, JA .
THORAX, 1999, 54 (07) :581-586
[6]   Efficacy of Acupuncture on Quality of Life, Functional Performance, Dyspnea, and Pulmonary Function in Patients with Chronic Obstructive Pulmonary Disease: Protocol for a Randomized Clinical Trial [J].
Cardoso, Renato Fleury ;
Rodrigues Lacerda, Ana Cristina ;
Lima, Vanessa Pereira ;
Fernandes de Oliveira, Lucas Frois ;
Fernandes de Oliveira, Sofia Frois ;
Araujo, Rafaela Paula ;
Fernandes e Castro, Cecylia Leiber ;
da Silva, Flavia Pereira ;
de Paiva, Lizania Vieira ;
Dietrich, Lia ;
Scheidt Figueiredo, Pedro Henrique ;
Costa, Henrique Silveira ;
Bernardo-Filho, Mario ;
de Sa-Caputo, Danubia Da Cunha ;
Mendonca, Vanessa Amaral ;
Taiar, Redha .
JOURNAL OF CLINICAL MEDICINE, 2022, 11 (11)
[7]  
Chen Biwei, 2023, J. Acupunct Res., V48, P32
[8]   The global economic burden of chronic obstructive pulmonary disease for 204 countries and territories in 2020-50: a health-augmented macroeconomic modelling study [J].
Chen, Simiao ;
Kuhn, Michael ;
Prettner, Klaus ;
Yu, Fengyun ;
Yang, Ting ;
Baernighausen, Till ;
Bloom, David E. ;
Wang, Chen .
LANCET GLOBAL HEALTH, 2023, 11 (08) :1183-1193
[9]   Chronic obstructive pulmonary disease [J].
Christenson, Stephanie A. ;
Smith, Benjamin M. ;
Bafadhel, Mona ;
Putcha, Nirupama .
LANCET, 2022, 399 (10342) :2227-2242
[10]   ATS statement: Guidelines for the six-minute walk test [J].
Crapo, RO ;
Casaburi, R ;
Coates, AL ;
Enright, PL ;
MacIntyre, NR ;
McKay, RT ;
Johnson, D ;
Wanger, JS ;
Zeballos, RJ ;
Bittner, V ;
Mottram, C .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 166 (01) :111-117